Ultime notizie per Nova (NASDAQ:NVMI) Azioni

Nova

Nova Ltd is a semiconductor equipment manufacturer. The company provides metrology solutions for process control used in semiconductor manufacturing. The company offers in-line optical and x-ray stand-alone metrology systems, as well as integrated optical metrology systems. The product range consists of Nova 2040, Nova 3090Next, Nova i500 and i500 Plus, Nova T500, Nova T600, Nova V2600, HelioSense 100, Nova Hybrid Metrology solution, NovaMars. The company generates the majority of its revenue from China. Geographically the company has its business spread across the region of Taiwan, Korea, China, the United States, and Europe.

Nova Measuring

Nova Ltd

ARM,QCOM,NVDA,MU,AMD,TSM,AVGO,NXPI,LRCX,INTC,ASML,ON,RMBS,LSCC,GFS,TSEM,SIMO,ADI,KLAC,MCHP,STM,AMAT

WIIM

ACLS

ACMR

ALGM

AMAT

ASML

AVGO

CAMT

ENTG

FORM

FSLR

INTC

KLAC

KLIC

LRCX

LSCC

MCHP

MKSI

MPWR

NVDA

NVMI

NXPI

QCOM

RMBS

SIMO

SITM

TSEM

UCTT

Shares of chip stocks are trading lower in sympathy with ASML, which fell after issuing soft guidance. Some stocks in the sector may also be down on reports indicating the US is discussing curbing chip exports to some countries.

AEHR

AMKR

CRDO

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MTSI

ONTO

SMTC

SWKS

Shares of semiconductor companies are trading higher amid overall market strength following Wednesday's Fed rate cut.

Nova shares are trading lower after Citigroup downgraded the stock from Buy to Neutral and lowered its price target from $273 to $224.

Citigroup analyst Atif Malik downgrades Nova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) from Buy to Neutral and lowers the price target from $273 to $224.

News

Downgrades

Price Target

Analyst Ratings

Citigroup Downgrades Nova to Neutral, Lowers Price Target to $224

U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Monday.
Shares of iTeos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITOS#NASDAQ">ITOS</a>) fell sharply in <a href="https://www.benzinga.com/quote/ITOS/analyst-ratings">today's pre-market trading.</a>
The company announced follow-up interim data from GALAXIES Lung-201.
iTeos Therapeutics shares dipped 13.7% to $14.40 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Vizsla Silver Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VZLA#NASDAQ">VZLA</a>) shares fell 11.4% to $1.94 in pre-market trading. Vizsla Silver announced a $65 million bought deal financing.</li>
<li>Murano Global Investments Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNO#NASDAQ">MRNO</a>) shares tumbled 11.1% to $8.89 in pre-market trading after jumping 36% on Friday.</li>
<li>Upstart Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>) shares fell 8.5% to $34.79 in pre-market trading. Upstart announced a proposed private offering of $300,000,000 of convertible senior notes due 2029.</li>
<li>Guardant Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GH#NASDAQ">GH</a>) shares dipped 8.2% to $24.60 in pre-market trading after gaining around 5% on Friday.</li>
<li>Hyliion Holdings Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HYLN#NYSE">HYLN</a>) shares fell 6.7% to $1.96 in pre-market trading after gaining 8% on Friday. Hyliion Holdings, last week, announced it has been awarded a $15 million + contract by the Office of Naval Research to develop its KARNO generator for Navy ships and stationary power applications.</li>
<li>Instil Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIL#NASDAQ">TIL</a>) shares declined 6.1% to $79.40 in pre-market trading. Instil Bio and ImmuneOnco announced a global registrational strategy for PD-l1xvegf bispecific antibody, SYN-2510/IMM2510, in non-small cell lung cancer and triple-negative breast cancer.</li>
<li>Canaan Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAN#NASDAQ">CAN</a>) fell 5.6% to $1.01 in pre-market trading after jumping 15% on Friday.</li>
<li>Solid Biosciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDB#NASDAQ">SLDB</a>) shares slipped 3% to $7.70 in pre-market trading after adding around 3% on Friday.</li>
<li>Nova Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) shares fell 3% to $200.64 in pre-market trading.</li>
<li>MicroStrategy Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) shares slipped 2.4% to $138.10 in pre-market trading amid a drop in the price of Bitcoin. MicroStrategy shares gained over 8% on Friday after the company announced the purchase of 18,300 bitcoin.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/40860420/jim-cramer-hold-on-to-builders-firstsource-heres-the-problem-with-viking-therapeutics">Jim Cramer: &#8216;Hold On&#8217; To Builders FirstSource, &#8216;Here&#8217;s The Problem&#8217; With Viking Therapeutics</a></li>
</ul>

Pre-Market Outlook

Markets

Movers

Trading Ideas

HYLN

ITOS

MRNO

MSTR

SLDB

UPST

VZLA

iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>) dipped 11.6% to $6.43. The company on Tuesday announced Phase 2 data for an investigational treatment for symptomatic Cerebral Cavernous Malformation (CCM).
Nikola shares dipped 10.4% to $7.28 on Monday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Sify Technologies Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIFY#NASDAQ">SIFY</a>) shares jumped 103% to $0.6719. Sify becomes first in India to achieve NVIDIA DGX-ready data center certification for liquid cooling to enable breakthrough AI performance.</li>
<li>BranchOut Food Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOF#NASDAQ">BOF</a>) gained 85% to $3.70.</li>
<li>SPAR Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGRP#NASDAQ">SGRP</a>) surged 65% to $2.3950 after the company announced it entered into a definitive agreement to be acquired by Highwire Capital for $2.50 per share.</li>
<li>Asset Entities Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASST#NASDAQ">ASST</a>) rose 62.7% to $2.31.</li>
<li>Conifer Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNFR#NASDAQ">CNFR</a>) shares jumped 56% to $1.0250 after the company announced that it completed the sale of its insurance agency operations for a $45 million consideration. The company appointed Brian Roney as CEO.</li>
<li>Auddia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) gained 44.6% to $1.25 after the company announced it recently launched both Apple CarPlay and Android Auto interfaces for its faidr mobile application.</li>
<li>Vaxcyte, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCVX#NASDAQ">PCVX</a>) surged 43.5% to $115.92 after the company announced it selected VAX-31 to advance to an adult Phase 3 program following topline results from its Phase 1/2 study.</li>
<li>Sable Offshore Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOC#NYSE">SOC</a>) gained 28.8% to $21.69.</li>
<li>Shoals Technologies Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) rose 21.8% to $6.57 after the company received a favorable legal ruling from the U.S. ITC in its patent infringement complaint against Voltage, LLC and a related foreign entity.</li>
<li>TC Biopharm (Holdings) Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBP#NASDAQ">TCBP</a>) jumped 17.5% to $6.55 after the company announced it dosed 5 new patients in its ACHIEVE Phase 2b trial.</li>
<li>AGM Group Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGMH#NASDAQ">AGMH</a>) rose 16.5% to $1.27.</li>
<li>Polestar Automotive Holding UK PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNY#NASDAQ">PSNY</a>) gained 16% to $1.4150 after the company appointed former Stellantis executive Jean-Francois Mady as its new CFO.</li>
<li>Chemomab Therapeutics Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMMB#NASDAQ">CMMB</a>) surged 15.8% to $2.34.</li>
<li>MediciNova, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNOV#NASDAQ">MNOV</a>) gained 15.3% to $1.73. MediciNova recently announced that it received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application, which covers MN-166 for post-COVID conditions.</li>
<li>GD Culture Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDC#NASDAQ">GDC</a>) rose 12.8% to $6.86.</li>
<li>Big Tree Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSY#NASDAQ">DSY</a>) jumped 12.6% to $5.99.</li>
<li>Avalo Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTX#NASDAQ">AVTX</a>) gained 11.4% to $8.29.</li>
<li>Motorsport Games Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSGM#NASDAQ">MSGM</a>) rose 11.3% to $1.3250.</li>
<li>Applied Optoelectronics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAOI#NASDAQ">AAOI</a>) gained 10.7% to $12.57 after Raymond James upgraded the stock from Market Perform to Outperform and announced a $17 price target.</li>
<li>Unity Software Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>) gained 9.4% to $17.91 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight.</li>
<li>Intchains Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICG#NASDAQ">ICG</a>) climbed 8.1% to $7.89.</li>
<li>Keros Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KROS#NASDAQ">KROS</a>) gained 8.1% to $49.04 after the company announced an update on enrollment in the Phase 2 TROPOS trial.</li>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) gained 4.5% to $12.94. Friday, the FDA granted Emergency Use Authorization to Novavax Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) for active immunization to prevent COVID-19 in individuals aged 12 and older.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Windtree Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) shares dipped 42.2% to $4.68.</li>
<li>Dyne Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYN#NASDAQ">DYN</a>) fell 31.7% to $31.47. The company announced new clinical data from its ongoing Phase 1/2 DELIVER trial of DYNE-251 in patients with Duchenne muscular dystrophy who are amenable to exon 51 skipping demonstrating unprecedented dystrophin expression and functional improvement in multiple cohorts.</li>
<li>Agape ATP Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) shares fell 31.3% to $1.75 after jumping 60% on Friday.</li>
<li>IO Biotech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOBT#NASDAQ">IOBT</a>) dipped 29.3% to $1.06 after the company announced the IDMC observed no new safety signals in the Phase 3 trial of IO102-IO103. Also, Morgan Stanley maintained an Overweight rating on the stock but lowered its price target from $7 to $4.</li>
<li>Brenmiller Energy Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNRG#NASDAQ">BNRG</a>) fell 25.8% to $1.1499. Brenmiller recently reported a year-over-year increase in H1 EPS results. Also, the company announced a projected pipeline valued up to $500 million.</li>
<li>Silexion Therapeutics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) dipped 22.8% to $1.13.</li>
<li>Four Seasons Education (Cayman) Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FEDU#NYSE">FEDU</a>) fell 21.8% to $13.30.</li>
<li>Quantum BioPharma Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNTM#NASDAQ">QNTM</a>) declined 21.6% to $3.55.</li>
<li>Applied DNA Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) fell 18.8% to $1.5506.</li>
<li>Xiao-I Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIXI#NASDAQ">AIXI</a>) dipped 18.6% to $3.99.</li>
<li>NANO Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) fell 16.1% to $8.49.</li>
<li>LightInTheBox Holding Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITB#NASDAQ">LITB</a>) declined 14.3% to $0.4455.</li>
<li>NovoCure Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCR#NASDAQ">NVCR</a>) fell 12.7% to $16.97 as the company announced planned CEO transition.</li>
<li>Geron Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GERN#NASDAQ">GERN</a>) fell 10.8% to $4.2350.</li>
<li>Nova Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) declined 9.6% to $202.16.</li>
<li>Tidewater Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDW#NYSE">TDW</a>) fell 8.5% to $81.15.</li>
<li>Sterling Infrastructure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRL#NASDAQ">STRL</a>) fell 8.5% to $109.35.</li>
<li>The Boeing Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) fell 8.3% to $159.27 ahead of the September 12 expiration of the company&#8217;s contract with the International Association of Machinists, which could lead to a potential strike. Additionally, Wells Fargo downgraded the stock from Equal-Weight to Underweight.</li>
<li>Avis Budget Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAR#NASDAQ">CAR</a>) dipped 8% to $75.43.</li>
<li>Marvell Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) fell 7.2% to $70.73.</li>
<li>Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) declined 7% to $20.52.</li>
<li>Applied Materials, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) fell 6.2% to $185.01.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/40683473/top-3-tech-and-telecom-stocks-which-could-rescue-your-portfolio-this-month">Top 3 Tech And Telecom Stocks Which Could Rescue Your Portfolio This Month</a></li>
</ul>

Intraday Update

AAOI

AGMH

AIXI

APDN

ASST

ATPC

AUUD

AVTX

BNRG

Chemomab Therapeutics Ltd. - American Depositary Shares

CMMB

CNFR

FEDU

GERN

IOBT

KROS

LITB

MNOV

MRVL

MSGM

NVAX

NVCR

PCVX

PSNY

QNTM

RXRX

SGRP

SHLS

SIFY

SLXN

STRL

TCBP

WINT

Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

ALAB

AMBA

AOSL

ASTI

DIOD

ENPH

INDI

LAES

NVTS

OLED

PLAB

POWI

QRVO

SEDG

SKYT

SLAB

SYNA

Shares of semiconductor stocks are trading lower amid overall market weakness. A drop in the price of NVIDIA may weigh down the sector.

Benchmark analyst Mark Miller maintains Nova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) with a Buy and raises the price target from $215 to $240.

Benchmark Maintains Buy on Nova, Raises Price Target to $240

U.S. stocks were higher, with the Dow Jones index gaining over 1% on Thursday.
Shares of Parker-Hannifin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) rose sharply during Thursday's session following better-than-expected fourth-quarter financial results and <a href="https://www.benzinga.com/quote/PH">upbeat FY25 guidance.</a>
Parker Hannifin reported fourth-quarter sales growth of 2% year over year to $5.186 billion and +3% organic growth, beating the consensus of $5.082 billion.
Parker-Hannifin shares jumped 9.8% to $562.79 on Thursday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Viasat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSAT#NASDAQ">VSAT</a>) gained 42.2% to $25.27 after the company reported better-than-expected first-quarter financial results.</li>
<li>XPEL, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPEL#NASDAQ">XPEL</a>) gained 35% to $42.65 after the company reported better-than-expected second-quarter financial results.</li>
<li>AxoGen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXGN#NASDAQ">AXGN</a>) shares surged 33.5% to $10.57 after the company reported better-than-expected second-quarter results.</li>
<li>CommScope Holding Company, Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COMM#NASDAQ">COMM</a>) climbed 30% to $2.7600 after the company reported better-than-expected second-quarter financial results.</li>
<li>DocGo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCGO#NASDAQ">DCGO</a>) rose 27.1% to $3.80 after the company reported better-than-expected quarterly sales.</li>
<li>Klaviyo, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVYO#NYSE">KVYO</a>) gained 25.2% to $28.91 after the company reported better-than-expected second-quarter financial results. Also, the company issued FY24 and Q3 revenue guidance above estimates.</li>
<li>Leslie&#8217;s, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LESL#NASDAQ">LESL</a>) rose 23.3% to $3.4050 following upbeat quarterly earnings.</li>
<li>Forward Air Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRD#NASDAQ">FWRD</a>) gained 19.6% to $26.90 following second-quarter results.</li>
<li>Clean Energy Fuels Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNE#NASDAQ">CLNE</a>) gained 19.2% to $2.8850 following quarterly earnings.</li>
<li>ICU Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICUI#NASDAQ">ICUI</a>) jumped 18.1% to $143.88 following strong quarterly results.</li>
<li>Under Armour, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UA#NYSE">UA</a>) gained 17.2% to $7.35 following first-quarter earnings.</li>
<li>SharkNinja, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SN#NYSE">SN</a>) rose 16% to $84.65 after the company reported better-than-expected quarterly financial results.</li>
<li>Zillow Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZG#NASDAQ">ZG</a>) gained 15.5% to $46.61 after the company reported better-than-expected quarterly financial results.</li>
<li>Nova Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) jumped 15% to $208.24 after the company reported better-than-expected second-quarter financial results and issued third-quarter guidance above estimates.</li>
<li>YETI Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YETI#NYSE">YETI</a>) gained 13.1% to $41.90 after the company reported better-than-expected second-quarter financial results and raised its FY24 adjusted EPS guidance above estimates.</li>
<li>Boot Barn Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) rose 11.4% to $128.93 after the company reported better-than-expected first-quarter financial results.</li>
<li>Sealed Air Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEE#NYSE">SEE</a>) gained 10.6% to $38.04 following quarterly results.</li>
<li>Eli Lilly and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) rose 9.1% to $842.14 after the company reported better-than-expected second-quarter financial results and raised its full-year guidance.</li>
<li>ON Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) gained 5% to $69.63.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40253347/top-3-utilities-stocks-that-could-lead-to-your-biggest-gains-this-month">Top 3 Utilities Stocks That Could Lead To Your Biggest Gains This Month</a></li>
</ul>

AXGN

BOOT

CLNE

COMM

DCGO

FWRD

ICUI

KVYO

LESL

VSAT

XPEL

YETI

Parker-Hannifin Posts Upbeat Earnings, Joins Under Armour, Zillow Group, YETI Holdings, Eli Lilly And Other Big Stocks Moving Higher On Thursday

Nova shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 guidance above estimates.

2024&nbsp;Third Quarter&nbsp;Financial&nbsp;Outlook
Management provided an&nbsp;outlook&nbsp;for the&nbsp;third quarter, the period ending&nbsp;September 30, 2024. Based on current estimates, management expects:
<ul>
<li>$168 million&nbsp;to&nbsp;$176 million&nbsp;in revenue</li>
<li>$1.39&nbsp;to&nbsp;$1.52&nbsp;in diluted GAAP EPS</li>
<li>$1.60&nbsp;to&nbsp;$1.73&nbsp;in diluted non-GAAP EPS</li>
</ul>

Guidance

Nova Expects Q3 Revenue Of $168M-$176M Vs $148.1M Est, Adj EPS Of $1.60-$1.73 Vs $1.36 Est

Earnings

Earnings Beats

Nova Q2 2024 Adj. EPS $1.61 Beats $1.36 Estimate, Sales $156.858M Beat $148.119M Estimate

AEIS

PDFS

VECO

WOLF

Shares of semiconductor stocks are trading lower in sympathy with Intel, which reported worse-than-expected Q2 financial results and issued soft guidance.

CEVA

CRUS

ICHR

WISA

Shares of chip stocks are trading lower amid overall market weakness. Recent earnings from large names in the sector may also be weighing on the sector.

Shares of ASLAN Pharmaceuticals Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASLN#NASDAQ">ASLN</a>) fell sharply during Wednesday's session after the company announced that its Singapore-incorporated, sole operating subsidiary has filed for <a href="https://www.benzinga.com/quote/ASLN/news">voluntary liquidation</a>.
ASLAN Pharmaceuticals shares dipped 38.7% to $0.68 on Wednesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Aptevo Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>) shares climbed 84% to $0.6073 after surging around 10% on Tuesday. Aptevo Therapeutics recently announced closing of $2.75 million offering.</li>
<li>Shimmick Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHIM#NASDAQ">SHIM</a>) shares climbed 49% to $3.0173 after the company received a $27.6 million subcontract for the Sunol Valley Water Treatment Plant Ozonation Project.</li>
<li>Aditxt, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTX#NASDAQ">ADTX</a>) shares climbed 45.3% to $2.3107. Aditxt and Evofem amended merger agreement.</li>
<li>Locafy Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCFY#NASDAQ">LCFY</a>) gained 31.2% to $7.15.</li>
<li>Autonomix Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) jumped 27.2% to $1.3505.</li>
<li>Alpha Teknova, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TKNO#NASDAQ">TKNO</a>) gained 18% to $1.60. Alpha Teknova 10% owner Telegraph Hill Partners Management Company, LLC bought a total of 12,096,773 shares at an average price of $1.24.</li>
<li>Asset Entities Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASST#NASDAQ">ASST</a>) shares climbed 17% to $1.8350.</li>
<li>Meiwu Technology Company Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WNW#NASDAQ">WNW</a>) gained 17% to $1.0650</li>
<li>Aehr Test Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) gained 16.4% to $19.60 after the company reported better-than-expected Q4 financial results and issued FY25 revenue guidance above estimates. Also, the company announced it entered into a stock purchase agreement and made $12.7 million in orders for its FOX WaferPak full wafer Contractors.</li>
<li>Allarity Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLR#NASDAQ">ALLR</a>) rose 14.5% to $0.2330. Allarity Therapeutics, last month, announced that it received notice from the NASDAQ Stock Market that it was granted a hearing.</li>
<li>ClearSign Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIR#NASDAQ">CLIR</a>) gained 14.4% to $0.9499 as the company received initial order from Birwelco.</li>
<li>The Honest Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HNST#NASDAQ">HNST</a>) gained 14% to $4.0350.</li>
<li>GLOBALFOUNDRIES Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>) climbed 12.7% to $61.36.</li>
<li>Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) rose 9.4% to $16.50 after the company announced a strategic partnership with CoreWeave.</li>
<li>fuboTV Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NYSE">FUBO</a>) climbed 9.1% to $1.5610</li>
<li>GitLab Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) gained 8.4% to $54.92 following a report suggesting the company is exploring a sale.</li>
<li>Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) rose 8% to $16.27 after the company announced a strategic partnership with CoreWeave.</li>
<li>V.F. Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>) gained 7.8% to $15.35 after the company announced it entered into a Stock and Asset Purchase Agreement to sell its Supreme brand to EssilorLuxottica for $1.5 billion in cash.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Cassava Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>) fell 29.8% to $9.51 after announcing changes in executive leadership. The company named Rick Barry as Executive Chairman and Principal Executive Office and said Remi Barbier resigned as President, CEO, and Board Member.</li>
<li>4D Molecular Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDMT#NASDAQ">FDMT</a>) declined 20.9% to $21.16. 4DMT announced Phase 2 PRISM interim results for intravitreal 4D-150 in a broad wet AMD population affirming favorable safety profile and robust clinical activity.</li>
<li>Five Below, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) shares dipped 19.7% to $81.93 after the company announced a CEO transition. Additionally, comparable sales decreased in the 10-week period ended July 13.</li>
<li>Sonim Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONM#NASDAQ">SONM</a>) fell 18.2% to $0.4138.</li>
<li>Adverum Biotechnologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADVM#NASDAQ">ADVM</a>) dipped 16.3% to $7.46. Adverum Biotechnologies revealed 26-week interim analysis results of Ixo-vec from LUNA Phase 2 trial at 2024 ASRS Annual Meeting.</li>
<li>Structure Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GPCR#NASDAQ">GPCR</a>) fell 16.2% to $37.44.</li>
<li>Cyclerion Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCN#NASDAQ">CYCN</a>) fell 13.7% to $2.50.</li>
<li>Scinai Immunotherapeutics Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNI#NASDAQ">SCNI</a>) dipped 11.8% to $4.68.</li>
<li>Luminar Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) fell 11.7% to $1.8974.</li>
<li>Viking Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>) dipped 10.8% to $50.89.</li>
<li>Onto Innovation Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONTO#NYSE">ONTO</a>) fell 10% to $214.17. Onto Innovation announced Dr. Stephen Schwartz has joined its board of directors.</li>
<li>ASML Holding N.V.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) shares declined 9.8% to $963.01. ASML reported better-than-expected second-quarter earnings, driven by robust sales in China and a surge in new bookings.</li>
<li>Aurora Innovation, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUR#NASDAQ">AUR</a>) fell 9.5% to $4.46.</li>
<li>Nova Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) declined 9.2% to $219.39.</li>
<li>Eightco Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCTO#NASDAQ">OCTO</a>) shares fell 9% to $0.48. Eightco Holdings recently said first-quarter revenue fell to $9.6 million from $15.9 million in the year-ago period.</li>
<li>Credo Technology Group Holding Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) dipped 8.8% to $30.87.</li>
<li>Siebert Financial Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIEB#NASDAQ">SIEB</a>) fell 8.5% to $1.7381 after gaining over 9% on Tuesday.</li>
<li>Spirit Airlines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAVE#NYSE">SAVE</a>) shares declined 8.4% to $2.8950 as the company issued soft second-quarter preliminary revenue estimates. The company estimated total revenue for the second quarter of 2024 to be approximately $1.28 billion, lower than previously expected primarily due to lower-than-expected non-ticket revenue.</li>
<li>Virpax Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) shares fell 8.1% to $1.3890 after jumping 41% on Tuesday.</li>
<li>Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) dipped 8% to $163.01.</li>
<li>Semtech Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) fell 7.4% to $33.66.</li>
<li>NaaS Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAAS#NASDAQ">NAAS</a>) fell 7.3% to $4.32.</li>
<li>e.l.f. Beauty, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) declined 7.1% to $175.56.</li>
<li>Safe and Green Development Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGD#NASDAQ">SGD</a>) shares dipped 7.1% to $0.38.</li>
<li>J.B. Hunt Transport Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) fell 7% to $163.74 after the company reported worse-than-expected second-quarter financial results.</li>
<li>QUALCOMM Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) fell 6.5% to $195.94 after HSBC downgraded the stock from Buy to Hold.</li>
<li>Snap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) fell 6.3% to $15.11 after Donald Trump made comments in support of TikTok.</li>
<li>NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) fell 5.2% to $119.82. Shares of semiconductor stocks traded lower amid reports Biden is considering further China restrictions.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39814468/alphabet-crowdstrike-and-2-other-stocks-insiders-are-selling">Alphabet, CrowdStrike And 2 Other Stocks Insiders Are Selling</a></li>
</ul>

ADTX

ADVM

ALLR

AMIX

APVO

ASLN

CLIR

CYCN

FDMT

FIVE

FUBO

GPCR

GTLB

HNST

JBHT

LAZR

LCFY

NAAS

OCTO

SAVA

SAVE

SCNI

SHIM

SIEB

SNAP

SONM

TKNO

VKTX

VRPX

Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of chip stocks are trading lower amid reports Biden is considering further China restrictions. The sector may also be down following soft guidance from ASML.

Nova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) has outperformed the market over the past 15 years by 31.68% on an annualized basis producing an average annual return of 44.21%. Currently, Nova has a market capitalization of $6.98 billion. 
Buying $100 In NVMI: If an investor had bought $100 of NVMI stock 15 years ago, it would be worth $23,325.24 today based on a price of $240.25 for NVMI at the time of writing.
<h3>Nova's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721075443_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Nova 15 Years Ago Would Be Worth This Much Today

Citigroup analyst Atif Malik maintains Nova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>) with a Buy and raises the price target from $223 to $273.

Citigroup Maintains Buy on Nova, Raises Price Target to $273

The semiconductor rally continues its unstoppable advance, fueled by the propulsion of artificial intelligence, with the U.S. chipmaking industry now soaring to a combined <a href="https://www.benzinga.com/markets/equities/24/06/39213777/nvidia-propels-semiconductor-industry-to-5-5-trillion-valuation-beginning-of-bigger-boom-says-an">valuation of $6.3 trillion.</a>
The PHLX Semiconductor Sector Index, mirrored by the Invesco PHLX Semiconductor ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOXQ#NYSE">SOXQ</a>), is poised for a 6% gain this week, marking its strongest performance in two months and achieving record high levels.
Since late October 2023, the index has surged by 78%, while the broader chip industry has seen an astonishing 169% increase from its October 2022 low.
In stark contrast, the broader tech sector, as tracked by the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), has risen by 39% from its October 2023 low and by 88% since October 2022.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="500" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/14143405/SOXQ_2024-06-14_20-32-29_7bf4b-1024x500.png" alt="" class="wp-image-389619" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/14143405/SOXQ_2024-06-14_20-32-29_7bf4b-1024x500.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/14143405/SOXQ_2024-06-14_20-32-29_7bf4b-300x147.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/14143405/SOXQ_2024-06-14_20-32-29_7bf4b-768x375.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/14143405/SOXQ_2024-06-14_20-32-29_7bf4b-1536x750.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/14143405/SOXQ_2024-06-14_20-32-29_7bf4b.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h3 class="wp-block-heading">Nvidia&#8217;s Dominance Poised To Continue</h3>
Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) has recently surpassed a $3 trillion valuation, representing nearly half of the broader U.S. semiconductor industry&#8217;s total worth. The company is now vying for the title of the world&#8217;s largest company, contending with giants such as Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) and Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>).
 &#8220;Given NVDA's dominance in the nascent AI space, it may be only a matter of time before NVDA surpasses MSFT to become the most valuable company in the world,&#8221; said George Smith, portfolio strategist for LPL Financial.
According to the expert, it is plausible that the NVDA rally will continue as tech-related ETFs are compelled to increase their exposure to the chipmaker during their next rebalancing.
<h3 class="wp-block-heading">This Week&#8217;s Best Performing Chipmakers</h3>
Surprisingly, Nvidia is not the top gainer among semiconductor stocks this week. 
While the leading chipmaker&#8217;s shares have rallied by 9.4%, six other semiconductor companies have outperformed Nvidia, showcasing even stronger gains.
Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) surged 22% this week, driven by stronger-than-expected earnings and an improved AI-related demand outlook from its top client, Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), following the Cupertino-based iPhone maker&#8217;s announcement of new AI initiatives at WWDC 2024. This marks Broadcom&#8217;s strongest week since the company went public in 2009.
British computer processor and software design company Arm Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) was the second-best performer among chipmakers, rising 14% and marking its sixth consecutive week of gains. Arm will join the Nasdaq 100 Index beginning June 24.
Qorvo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>) followed closely, with its shares up 13% this week.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Name</td>
<td>Market Cap</td>
<td>Price Chg. % (5D)</td>
</tr>
<tr>
<td>Broadcom Inc.</td>
<td>$ 803.67B</td>
<td>22.74%</td>
</tr>
<tr>
<td>Arm Holdings plc</td>
<td>$ 161.90B</td>
<td>13.95%</td>
</tr>
<tr>
<td>Qorvo, Inc.</td>
<td>$ 10.78B</td>
<td>13.25%</td>
</tr>
<tr>
<td>Axcelis Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACLS#NASDAQ">ACLS</a>)</td>
<td>$ 4.52B</td>
<td>11.08%</td>
</tr>
<tr>
<td>Universal Display Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLED#NASDAQ">OLED</a>)</td>
<td>$ 9.53B</td>
<td>9.70%</td>
</tr>
<tr>
<td>NVIDIA Corporation</td>
<td>$ 3,250.83B</td>
<td>9.42%</td>
</tr>
<tr>
<td>Nova Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVMI#NASDAQ">NVMI</a>)</td>
<td>$ 6.96B</td>
<td>9.13%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated on June 14 at 2:13 p.m. ET</figcaption></figure>
Read now: <a href="https://www.benzinga.com/markets/equities/24/06/39334146/consumer-sentiment-tumbles-in-june-reaches-7-month-low-high-prices-as-well-as-weakening-incomes-">Consumer Sentiment Tumbles In June, Reaches 7-Month Low: &#8216;High Prices As Well As Weakening Incomes&#8217; Raise Concerns</a>
Photo: Shutterstock

Equities

Large Cap

Mid Cap

Sector ETFs

Broad U.S. Equity ETFs

Tech

ETFs

AAPL

MSFT

SOXQ

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

Semiconductors Hit Record Highs As Industry Reaches $6.3 Trillion: 5 Chip Stocks That Outpaced Nvidia This Week

Comments

Nova

Notizie

Ultime notizie per Nova (NASDAQ:NVMI) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO